Clinical trial · no report yet · Phase 3
NCT01169337
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
- NCT01169337 ↗
- Active not recruiting
- National Cancer Institute (NCI)
- 11 commentary sources found
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 11 |
The trial
ClinicalTrials.gov- Official title
- Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
- Phase
- Phase 3
- Status
- Active not recruiting
- Conditions
- Light Chain Deposition Disease; Smoldering Multiple Myeloma
- Interventions
- Clinical Observation; Lenalidomide; Quality-of-Life Assessment
- Arms
- Arm A (lenalidomide) · Experimental
- Arm B (observation) · Active comparator
- Enrollment
- 226
- Primary outcomes
- Proportion of Patients With Grade 3 Adverse Events That Effect Vital Organ Function or Any Grade 4 or Higher Non-hematologic Adverse Events (Phase II Primary Endpoint)
- 2-year Progression-free Survival (PFS) Rate (Phase III Primary Endpoint)
- Sponsor
- National Cancer Institute (NCI)
- Start
- Jan 24, 2011
- Primary completion
- Jan 25, 2019
- Results posted
- Yes
- Registry record
- NCT01169337 · updated Oct 1, 2026
Publications
linked from the registry- Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma. J Clin Oncol. 2020 Apr 10;38(11):1126-1137. doi: 10.1200/JCO.19.01740. Epub 2019 Oct 25. PubMed 31652094